Mar 11, 2021 / 07:25PM GMT
Carter Lewis Gould - Barclays Bank PLC, Research Division - Senior Analyst
Okay. Good afternoon, and welcome to day 3 of the Barclays Global Healthcare Conference. My name is Carter Gould, senior biopharma analyst here at Barclays, and welcome. We are pleased to welcome Alector to next up for a virtual fireside chat. Representing the company is President and COO, Shehnaaz Suliman. Shehnaaz, welcome very much.
Shehnaaz Suliman - Alector, Inc. - President , COO & Interim Chief Business Officer
Thank you, Carter. It's a pleasure to be here.
Carter Lewis Gould - Barclays Bank PLC, Research Division - Senior Analyst
I believe you're going to make some opening comments, and then we'll hop into Q&A.
Shehnaaz Suliman - Alector, Inc. - President , COO & Interim Chief Business Officer
Absolutely, I'll be delighted to do that. So we, at Alector, have been pioneering immuno-neurology since Arnon Rosenthal founded and CEOs started the company about 8 years ago. And what that
Alector Inc at Barclays Global Healthcare Conference (Virtual) Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot